Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gang An

Showing results (161-170 of 274) with videos related to

Pageof 28
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 8, 2022
[The Clinical Significance of Oligoclonal Bands in Patient with Multiple Myeloma]Jia-Hui Liu, Hui-Shou Fan, Wen-Qiang Yan, et al.
Leukemia & Lymphoma|July 12, 2022
The clinical characteristics and prognosis of patients with primary plasma cell leukemia (pPCL) according to the new IMWG definition criteriaWenqiang Yan, Huishou Fan, Jingyu Xu, et al.
BMC Medical Genetics|February 18, 2017
BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phaseDehui Zou, Shuhua Yi, Rui Cui, et al.
Investigative Ophthalmology & Visual Science|February 5, 2024
Screening Mutations of the Monogenic Syndromic High Myopia by Whole Exome Sequencing From MAGIC ProjectChong Chen, Gang An, Xiaoguang Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 21, 2012
[The expression of microRNA-155 and microRNA-146a and its' clinical value in chronic lymphoproliferative disorders]Ke-shu Zhou, Zhen Yu, Shu-hua Yi, et al.
Biomarker Research|May 23, 2026
Single-cell transcriptomic mapping of immune heterogeneity across angioimmunoblastic T-cell lymphoma subtypesHuimin Liu, Yang Tong, Meijuan Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2026
Single-Cell Profiling Identifies SLC2A5-Mediated Fructose Metabolism as a Vulnerability in Primary CNS LymphomaQiaoli Wu, Qianru Zhang, Wenqiang Yan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 15, 2013
[Analysis of the efficacy and prognosis on first-line autologous hematopoietic stem cell transplantation of patients with multiple myeloma]De-hui Zou, Wei-wei Sui, Shu-huai Yi, et al.
Cancer|October 17, 2023
Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myelomaWenqiang Yan, Jingyu Xu, Huishou Fan, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 9, 2021
[Clinical Analysis of Patients with MGUS, Primary Light Chain Amyloidosis, Multiple Myeloma or Multiple Myeloma with Concurrent Amyloidosis]Xue-Han Mao, Shu-Hui Deng, Wei-Wei Sui, et al.
Pageof 28

Showing results (161-170 of 274) with videos related to

Sort By:
Pageof 28
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 8, 2022
[The Clinical Significance of Oligoclonal Bands in Patient with Multiple Myeloma]Jia-Hui Liu, Hui-Shou Fan, Wen-Qiang Yan, et al.
Leukemia & Lymphoma|July 12, 2022
The clinical characteristics and prognosis of patients with primary plasma cell leukemia (pPCL) according to the new IMWG definition criteriaWenqiang Yan, Huishou Fan, Jingyu Xu, et al.
BMC Medical Genetics|February 18, 2017
BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phaseDehui Zou, Shuhua Yi, Rui Cui, et al.
Investigative Ophthalmology & Visual Science|February 5, 2024
Screening Mutations of the Monogenic Syndromic High Myopia by Whole Exome Sequencing From MAGIC ProjectChong Chen, Gang An, Xiaoguang Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 21, 2012
[The expression of microRNA-155 and microRNA-146a and its' clinical value in chronic lymphoproliferative disorders]Ke-shu Zhou, Zhen Yu, Shu-hua Yi, et al.
Biomarker Research|May 23, 2026
Single-cell transcriptomic mapping of immune heterogeneity across angioimmunoblastic T-cell lymphoma subtypesHuimin Liu, Yang Tong, Meijuan Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2026
Single-Cell Profiling Identifies SLC2A5-Mediated Fructose Metabolism as a Vulnerability in Primary CNS LymphomaQiaoli Wu, Qianru Zhang, Wenqiang Yan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 15, 2013
[Analysis of the efficacy and prognosis on first-line autologous hematopoietic stem cell transplantation of patients with multiple myeloma]De-hui Zou, Wei-wei Sui, Shu-huai Yi, et al.
Cancer|October 17, 2023
Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myelomaWenqiang Yan, Jingyu Xu, Huishou Fan, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 9, 2021
[Clinical Analysis of Patients with MGUS, Primary Light Chain Amyloidosis, Multiple Myeloma or Multiple Myeloma with Concurrent Amyloidosis]Xue-Han Mao, Shu-Hui Deng, Wei-Wei Sui, et al.
Pageof 28